This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Sep. 4, 2013



















Not an AzPA member?

Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings.


 



Awareness of orphan therapies offers opportunities for pharmacists
American Society of Health-System Pharmacists
Caring for patients with rare diseases is all in a day's work for Jeanine Utz, adjunct assistant professor of experimental and clinical pharmacology at the University of Minnesota, Fairview, in Minneapolis. Utz is a researcher and clinician specializing in the care of patients with lysosomal storage diseases. She is also part of the patient care team at the phenylketonuria clinic at the University of Minnesota Medical Center, Fairview.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




AREA & ASSOCIATION NEWS


Save the date — AzPA Anticoagulation Certificate Program
AzPA


Completely revised, the AzPA Anticoagulation Certificate Program will be presented Oct. 25. Registration will be open in early September.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




PHARMACY UPDATES


Pharmacies take after banks, offering cash rewards for new customers
The Post and Courier
In David Slade's last column, he wrote about cash incentives that banks offer to attract new customers, but did you know that pharmacies do the same thing? In fact, some pharmacies offer larger cash incentives for new customers than banks.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Tylenol bottles will have new cap and warning to prevent overdoses
Time
Bottles of Tylenol sold in the U.S. will soon bear red warnings alerting users to the potentially fatal risks of taking too much of the popular pain reliever.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


CVS bans doctors 'over-prescribing' pain meds
Drug Topics
In response to the federal crackdown on prescription fraud, CVS Caremark has told physicians it believes over prescribe controlled substances to take their business elsewhere.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Most medications, vaccines safe for nursing mothers, infants
Medscape
Although most medications and immunizations are safe for nursing mothers and infants, physicians should consult the National Institutes of Health online database, LactMed, when considering medications for nursing mothers, according to an American Academy of Pediatrics report in Pediatrics.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE



TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    FDA to regulate compounding pharmacies (MintPress News)
HIPAA has new rule changes effective Sept. 23. Is your pharmacy ready? (AzPA)
The use of microspheres in parenteral drug delivery (By Dr. Afsaneh Motamed-Khorasani)
RxAlly closure announcement (AzPA)
Study: Antipsychotic drugs raise diabetes risk in children (The Wall Street Journal)

Don't be left behind. Click here to see what else you missed.


IN THE NEWS


CDC encourages flu vaccination as soon as possible
American Pharmacists Association
The CDC recently encouraged pharmacists and other healthcare providers to get an early jump on preparations for the 2013-14 influenza season. As demonstrated by the 2012-13 season, influenza activity can begin early and cause severe illness. Therefore, the CDC is encouraging providers to begin vaccinating patients as soon as vaccine is available in their community. The flu vaccine is recommended for most individuals 6 months or older, with few exceptions.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Drug companies faulted for not testing drugs in kids
Medscape
The FDA is faulting three pharmaceutical companies for not complying with a federal law that requires them to study their products in children. The FDA chided the companies in noncompliance letters mailed out this spring. The letters were posted on the FDA website Aug. 27, along with responses from the pharmaceutical companies.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Parents' goals guide ADHD treatment choice
HealthDay News
Parents' goals for treating their child's attention deficit hyperactivity disorder tend to steer the treatment in a distinct direction, new research shows. When parents' main concern was their child's academic performance, they often chose medications as the treatment of choice, but if parents were more worried about their child's behavior, they tended to opt for behavioral therapy as an initial treatment.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ACA in 2014: What patients need to know
American Pharmacists Association
Patient awareness of the Affordable Care Act is increasing, but the Obama administration has a lot of work to do on promoting the controversial healthcare reform law as the clock ticks. Tied to 2014 are major provisions of ACA such as the option for states to expand Medicaid and the health insurance marketplaces, for which open enrollment begins Oct. 1.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FEATURED ARTICLE
TRENDING ARTICLE
MOST POPULAR ARTICLE
Illicit prescription painkiller use may lead to heroin abuse
Pharmacy Times
The number of people who have begun using heroin in the United States has increased in recent years, and a report released in August suggests that nonmedical or recreational use of prescription pain medications may be to blame.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
FDA warns of rare but serious skin reactions with acetaminophen
Pharmacy Practice News
Acetaminophen carries the risk for rare but serious and potentially fatal skin reactions, the FDA warned Aug. 1. The risk is present both in prescription and over-the-counter products containing the pain reliever and fever reducer, whether it is the single active ingredient or is combined with other medications.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
FDA to regulate compounding pharmacies
MintPress News
After a deadly meningitis outbreak traced to a New England compounding pharmacy killed at least 50 Americans last year, the U.S. government is poised to step in and increase regulation of these niche facilities through the FDA.

Share on FacebookTwitterShare on LinkedinE-mail article
read more


MEDICATION UPDATES


Current therapeutic strategies for the treatment of acute bronchiolitis
By Dr. Afsaneh Motamed-Khorasani
The hospital admission rate of children suffering from bronchioloitis has doubled over the past 10 to 15 years. Despite this increase, the optimal treatment method for bronchiolitis is still under controversy. Bronchodilators and corticosteroids are the commonly used drugs for the treatment of this disease. However, corticosteroids are not effective for bronchioloitis. Recently, nebulized epinephrine has demonstrated a marked relief in bronchioloitis patients.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Illicit prescription painkiller use may lead to heroin abuse
Pharmacy Times
The number of people who have begun using heroin in the United States has increased in recent years, and a report released in August by the Substance Abuse and Mental Health Service Administration suggests that nonmedical or recreational use of prescription pain medications may be to blame.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Generic and therapeutic drug substitutions can help lower Medicare costs
Medical News Today
Therapeutic drug substitutions have the potential to double or even triple annual cost savings compared with savings achieved with generic substitutions, according to O. Kenrik Duru and colleagues from the University of California, Los Angeles. Therapeutic drug substitutions involve the use of less expensive substitutes that are not equivalent but have a similar treatment effect as the original medication.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword MEDICARE.


Study: New diabetes drug seems safe for heart
HealthDay News
The new diabetes drug Onglyza has no effect, good or bad, on a patient's risk for heart attacks, a new study finds. However, the researchers from Brigham and Women's Hospital in Boston did find a surprising rise in hospitalizations for heart failure among those who took the medication compared to those who did not.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


 

AzPA Pharmacy Flash
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Danielle Wegert, Content Editor, 469.420.2696   
Contribute news

Disclaimer: The AzPA Pharmacy Flash is a weekly roundup of articles of interest to pharmacists and pharmacy professionals. This email may contain an advertisement of AzPA and/or third party products and services. Opinions expressed in these articles do not necessarily reflect the views of AzPA or its advertising partners. The AzPA Pharmacy Flash is compiled by MultiBriefs, a division of MultiView, Inc. Factual errors are the responsibility of the listed publication.

This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Sept. 4, 2013
Aug, 28, 2013
Aug. 21, 2013
Aug. 14, 2013



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063